You are here: Industry Insights > acquisition

News List

Veristat strengthens its European presence with acquisition of The Clinical Trial Company pharmaceutical-business-review
January 09, 2020
Veristat, a full-service CRO, announced that it has completed the acquisition of The Clinical Trial Company, a global Contract Research Organization headquartered in Europe.
Astellas has announced its acquisition of Xyphos for $665m europeanpharmaceuticalreview
January 09, 2020
Xyphos Biosciences will become a wholly owned subsidiary of Astellas Pharma following an acquisition made by the latter company.
Galen acquires Nordic-based POA Pharma in multi-million pound deal pharmaceutical-technology
January 09, 2020
Northern Ireland-based, globally focused pharmaceutical sales and marketing firm Galen has acquired Swedish-headquartered POA Pharma in a multi-million pound takeover agreement.
The top 10 largest biopharma M&A deals in 2019 fiercepharma
January 07, 2020
Biopharma M&A got a big boost moneywise in 2019. The three largest—Bristol-Myers Squibb for Celgene, AbbVie for Allergan, and Amgen for Celgene’s psoriasis drug Otezla—together delivered more than $150 billion. Valued at $74 billion ...
Astellas Acquires Xyphos Biosciences americanpharmaceuticalreview
January 06, 2020
Astellas Pharma announced the company has acquired Xyphos Biosciences. With the acquisition Astellas will gain Xyphos' novel and proprietary ACCEL (Advanced Cellular Control through Engineered Ligands) technology platform.
Charles River Laboratories Completes the Acquisition of HemaCare Corporation firstwordpharma
January 05, 2020
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of HemaCare Corporation (OTCMKTS: HEMA) for approximately $380 million in cash, or $25.40 per HemaCare share.
Patient Experiences Modestly Worse After Hospital Acquisition drugs
January 03, 2020
Modestly worse patient experiences are seen following hospital acquisition by another hospital, according to a study published in the Jan. 2 issue of the New England Journal of Medicine.
Johnson & Johnson Acquires TARIS Biomedical americanpharmaceuticalreview
January 02, 2020
Johnson & Johnson announced the acquisition of TARIS Biomedical, a privately-owned biotechnology company specializing in the development of a novel drug delivery technology ...
Charles River Laboratories to buy HemaCare for $380m pharmaceutical-business-review
December 20, 2019
Charles River Laboratories International has agreed to acquire human-derived cellular products provider HemaCare for around $380m in cash.
Roche concludes acquisition of Spark Therapeutics, Inc. to strengthen presence in gene therapy worldpharmanews
December 20, 2019
Roche and Spark Therapeutics, Inc. announced the completion of the acquisition following the receipt of regulatory approval from all government authorities required by the merger agreement.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page